Pediatrik Hematoloji ve Kemik İliği Transplantasyonu Yapılan Hastalarda Nörolojik Bulgular
Özet
Çocukluk çağı hematolojik hastalıkları ve kemik iliği nakli süreçleri, tedaviye bağlı komplikasyonlar veya hastalığın kendisi nedeniyle çeşitli nörolojik sorunlara yol açabilmektedir. Enfeksiyonlar, ilaç toksisitesi, metabolik süreçler ve immün sistem reaksiyonları bu nörolojik bozuklukların temel nedenleri arasında yer almaktadır. Erken tanı ve zamanında müdahale, mortalite ve morbidite riskini azaltmak ve klinik sonuçları iyileştirmek için hayati önem taşır.
Childhood hematological diseases and bone marrow transplantation processes can lead to various neurological complications due to either the underlying condition or therapeutic interventions. Infections, drug toxicity, metabolic processes, and immune system reactions represent the primary drivers behind these neurological impairments. Early diagnosis and timely clinical intervention are essential to mitigate mortality and morbidity risks while improving overall patient outcomes.
Referanslar
Sussman J.D, Davies-Jones G.A.B. Neurologic Manifestations of Hematologic Disorders. Aminoff M, Josephson S.A (eds). Aminoff’s Neurology and General Medicine. 5th edition. California: Academic Press; 2014.p.505-537.
Pruitt AA, Graus F, Rosenfeld MR. Neurological complications of transplan- tation: Part 1: Hematopoietic cell transplantation. Neurohospitalist. 2013;3:24–38.
Maffini E, Festuccia M, Brunello L, Boccadoro M, Giaccone L, Bruno B. Neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23:388–397.
Azik F, Yazal Erdem A, Tavil B, Bayram C, Tunç B, Uçkan D. Neurological complications after allogeneic hematopoietic stem cell transplantation in children, a single center experience. Pediatr Transplant. 2014 Jun;18(4):405-11.
Cordelli DM, Masetti R, Zama D, et al. Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation. Front Pediatr. 2017 May 15;5:105.
Lee YJ, Yum MS, Kim EH, et al. Clinical Characteristics of Transplant-associated Encephalopathy in Children. J Korean Med Sci. 2017 Mar;32(3):457-464.
Bleggi-Torres LF, de Medeiros BC, Werner B, et al. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant. 2000 Feb;25(3):301-7.
Bonardi M, Turpini E, Sanfilippo G, Mina T, Tolva A, Zappoli Thyrion F. Brain Imaging Findings and Neurologic Complications after Allogenic Hematopoietic Stem Cell Transplantation in Children. Radiographics. 2018 Jul-Aug;38(4):1223-1238.
Nishiguchi T, Mochizuki K, Shakudo M, Takeshita T, Hino M, Inoue Y. CNS complications of hematopoietic stem cell transplantation. AJR Am J Roentgenol 2009;192(4):1003–1011.
Sarbay H, Demir ÜF, Yılmaz G, Atay AA, Malbora B. Ifosfamide induced encephalopathy in a child with osteosarcoma. J Oncol Pharm Pract. 2021 Jul;27(5):1302-1306.
Maher OM, Silva JG, Huh WW, et al. Etiologies and Impact of Readmission Rates in the First 180 Days After Hematopoietic Stem Cell Transplantation in Children, Adolescents, and Young Adults. J Pediatr Hematol Oncol. 2017 Nov;39(8):609-613.
Bartynski W. Posterior reversible encephalopathy syndrome, part 2: con- troversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol (2008) 29(6):1043–9.
Server A, Bargalló N, Fløisand Y, Sponheim J, Graus F, Hald JK. Imaging spectrum of central nervous system complications of hematopoietic stem cell and solid organ transplantation. Neuroradiology 2017;59(2):105–126.
Masetti R, Cordelli DM, Zama D, et al. PRES in children undergoing hematopoietic stem cell or solid organ transplan- tation. Pediatrics 2015;135(5):890–901.
Dulamea AO, Lupescu IG. Neurological complications of hematopoietic cell transplantation in children and adults. Neural Regen Res. 2018 Jun;13(6):945-954.
Khanal P, Awan F, Nguyen V. Etoposide-induced posterior reversible encephalopathy syndrome. Ann Hematol. 2013 Apr;92(4):561-2.
Cordelli DM, Masetti R, Bernardi B, et al. Status epilepticus as a main manifestation of posterior reversible encephalopathy syndrome after pediatric hematopoietic stem cell transplantation. Pediatr Blood Cancer (2012) 58(5):785–90.
Siegal D, Keller A, Xu W, et al. Central nervous system complications after allogeneic hematopoietic stem cell transplanta- tion: incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant (2007) 13(11):1369–79.
Onder AM, Lopez R, Teomete U, et al. Posterior reversible encephalopathy syndrome in the pediatric renal popula- tion. Pediatr Nephrol (2007) 22(11):1921–9.
Mora E, Smith EM, Donohoe C, Hertz DL. Vincristine-induced peripheral neuropathy in pediatric cancer patients. Am J Cancer Res. 2016 Nov 1;6(11):2416-2430.
Bauwens D, Hantson P, Laterre PF, et al. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma. 2005 Nov;46(11):1671-4.
Pruitt AA, Graus F, Rosenfeld MR. Neurological complications of transplantation: part I: hematopoietic cell transplantation. Neurohospitalist. 2013 Jan;3(1):24-38.
Panda P.K. Neurological Complications of Childhood Hematological Disorders and Solid Malignancies: A Brief Review. Int Clin Pract Hematol 2019; 2(1): 07-11.
Higman MA, Port JD, Beauchamp NJ Jr, Chen AR. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant. 2000 Oct;26(7):797-800.
Bauwens D, Hantson P, Laterre PF, et al. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma. 2005 Nov;46(11):1671-4.
Levine DS, Navarro OM, Chaudry G, Doyle JJ, Blaser SI. Imaging the complications of bone marrow transplantation in children. RadioGraphics 2007;27(2):307–324.
Erbey F, Dur AH, Atay D, Akçay A, Tecimer T, Öztürk G. Successful treatment of BCG-related immune reconstitution inflammatory syndrome following ex vivo T-cell-depleted haploidentical hematopoietic stem cell transplantation: A case report. Pediatr Transplant. 2019 Aug;23(5):e13464.
Gatti-Mays ME, Manion M, Bowen LN, et al. Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report. Bone Marrow Transplant. 2016 Dec;51(12):1622-1624.
Quintas S, Sánchez P, López M, Vivancos J. Neuroradiological worsening of brain abscess after adalimumab and methotrexate withdrawal: Do not forget Immune Reconstitution Inflammatory Syndrome. J Clin Neurosci. 2019 Apr;62:240-242.
Shah RM, Waugh S, Ng KF, Gennery AR, Slatter M, Cant AJ. Enterovirus-Related Immune Reconstitution Inflammatory Syndrome (IRIS) Following Haploidentical Stem Cell Transplantation in an MHC Class II-Deficient Child. J Clin Immunol. 2017 Jul;37(5):419-421.
Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, Straube A. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology. 2003 Mar 11;60(5):842-8.
Yamada K, Shrier DA, Rubio A, et al. Imaging findings in intracranial aspergillosis. Acad Radiol. 2002 Feb;9(2):163-71.
Mueller-Mang C, Mang TG, Kalhs P, Thurnher MM. Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature. Neuroradiology 2006;48(2):84–89.
Yoshida S, Hayakawa K, Yamamoto A, Kuroda H, Imashuku S. The central nervous system complications of bone marrow transplantation in children. Eur Radiol. 2008 Oct;18(10):2048-59.
Zhang XH, Wang QM, Chen H, et al. Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2016 Oct;95(10):1637-43.
Rabinstein AA, Atkinson JL, Wijdicks EF. Emergency craniotomy in patients worsening due to expanded cerebral hematoma: to what purpose? Neurology. 2002 May 14;58(9):1367-72.
Labrador J, Lopez-Anglada L, Perez-Lopez E, et al. Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients. Haematologica. 2013 Mar;98(3):437-43.
Coplin WM, Cochran MS, Levine SR, Crawford SW. Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain. 2001 May;124(Pt 5):1043-51.
Sadighi Z, Sabin ND, Hayden R, Stewart E, Pillai A. Diagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation. J Child Neurol. 2015 Sep;30(10):1307-14.
Jodele S, Dandoy CE, Myers KC, et al. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transfus Apher Sci. 2016 Apr;54(2):181-90.
Jodele S, Laskin BL, Dandoy CE, et al. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev. 2015 May;29(3):191-204.
Dvorak CC, Higham C, Shimano KA. Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management. Front Pediatr. 2019 Apr 9;7:133.
Duléry R. Neurological Complications. Carreras E, Dufour C, Mohty M, Kröger N (eds). The EBMT Handbook. Switzerland:Springer;2019.p.403-407.
Nasilowska-Adamska B, Lysiak Z, Halaburda K, Szczepinski A, Ejduk A, Marianska B. Guillain-Barre syndrome--pathological connection with GvHD after allogeneic bone marrow transplantation. Ann Transplant. 2006;11(3):10-1.
Stephenson AL, Mackenzie IR, Levy RD, Road J. Myositis associated graft-versus-host-disease presenting as respiratory muscle weakness. Thorax. 2001;56:82–4.
Lefvert AK, Björkholm M. Antibodies against the acetylcholine receptor in hematologic disorders: implications for the development of myasthenia gravis after bone marrow grafting. N Engl J Med. 1987;317:170.
Jayakumar I, Uppuluri R, Lakshmanan C, Kumar Gowdhaman A, Vellaichamy Swaminathan V, Raj R. Risk-adapted therapy for the management of cytokine release syndrome in children undergoing unmanipulated haploidentical stem cell transplantation. Pediatr Transplant. 2021 Aug;25(5):e13964.
Matsuo Y, Kamezaki K, Takeishi S, et al. Encephalomyelitis mimicking multiple sclerosis associated with chronic graft-versus-host disease after allogeneic bone marrow transplantation. Intern Med. 2009;48(16):1453-6.
Kassa C, Reményi P, Sinkó J, Kállay K, Kertész G, Kriván G. Successful nivolumab therapy in an allogeneic stem cell transplant child with post-transplant lymphoproliferative disorder. Pediatr Transplant. 2018 Dec;22(8):e13302.
Kaiafa G, Savopoulos C, Kanellos I, et al. Anemia and stroke: Where do we stand? Acta Neurol Scand. 2017;135(6):596-602.
Rojas Hernandez C, Oo T. Advances in mechanisms, diagnosis, and treatment of pernicious anemia. Discov Med. 2015;19(104):159-168.
Akdal G, Yener GG, Ada E, Halmagyi GM. Eye movement disorders in vitamin B12 deficiency: two new cases and a review of the literature. Eur J Neurol. 2007 Oct;14(10):1170-2.
Glaser K, Girschick HJ, Schropp C, Speer CP. Psychomotor development following early treatment of severe infantile vitamin B12 deficiency and west syndrome – Is everything fine? A case report and review of literature. Brain Dev. 2015;37(3):347-351.
DeBaun MR, Kirkham FJ. Central nervous system complications and management in sickle cell disease. Blood. 2016 Feb 18;127(7):829-38.
Nemtsas P, Arnaoutoglou M, Perifanis V, Koutsouraki E, Orologas A. Neurological complications of beta-thalassemia. Ann Hematol. 2015 Aug;94(8):1261-5.
Erdur C.B, Güzin Y. Çocuklarda hipolipidemiler. İzmir Dr. Behçet Uz Çocuk Hast. Dergisi 2016; 6(1):1-8.
Verma S.K, Mishra M.K, Kumar R, Kumar A, Nimesh N. Neurologıcal manifestations in children with haematological malignancies. J. Evid. Based Med. Healthc. 2019 Jan; 6(1):56-60.
Schmidt K, Schulz AS, Debatin KM, et al. CNS complications in children receiving chemotherapy or hematopoietic stem cell transplantation: retrospective analysis and clinical study of survivors. Pediatr Blood Cancer 2008;50(2):331-336.
Waber DP, Silverman LB, Catania L, et al. Outcomes of a randomized trial of hyper-fractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic Leukaemia: therapeutic efficacy and neurotoxicity. J Clin Oncol 2004;22(13):2701-2707.
Baniel CC, Donaldson SS, Aftandilian C, Hiniker SM. Paraneoplastic Neurologic Symptoms in a Pediatric Patient with Hodgkin Lymphoma. Cancer Invest. 2021 Feb;39(2):159-162.
Demirsoy U, Alparslan B, Şen MC, et al. More than Ophelia syndrome: Multiple paraneoplastic syndromes in pediatric Hodgkin lymphoma. Turk J Pediatr. 2019;61(1):139-141.
Sakuta R, Tomita Y, Ohashi M, Nagai T, Murakami N. Idiopathic hypereosinophilic syndrome complicated by central sinovenous thrombosis. Brain Dev. 2007 Apr;29(3):182-4.
Giuffrida G, Markovic U, Parisi M, Nicolosi D, Calafiore V. Acquired hemophilia in a 7-year-old girl successfully treated with recombinant FVIIA and steroids: A case report. Clin Case Rep. 2020 Dec 3;9(2):638-643.
Kongstad C, Mikkelsen TS, Hvas AM. Disseminated intravascular coagulation in children with cancer: A systematic review. Pediatr Hematol Oncol. 2020 Aug;37(5):390-411.
Hamedani AG, Cole JW, Mitchell BD, Kittner SJ. Meta-analysis of factor V Leiden and ischemic stroke in young adults: the importance of case ascertainment. Stroke. 2010 Aug;41(8):1599-603.
Raible MD. Hematologic complications of heparin-induced thrombocytopenia. Semin Thromb Hemost. 1999;25 Suppl 1:17-21.
Pohl C, Harbrecht U, Greinacher A, et al. Neurologic complications in immune-mediated heparin-induced thrombocytopenia. Neurology. 2000 Mar 28;54(6):1240-5.
Hollist M, Au K, Morgan L, et al. Pediatric Stroke: Overview and Recent Updates. Aging Dis. 2021 Jul 1;12(4):1043-1055.
